Liver Diseases  >>  entecavir  >>  Phase 3
Welcome,         Profile    Billing    Logout  

17 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
entecavir / Generic mfg.
NCT00035633: A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen

Completed
3
US
Entecavir
Bristol-Myers Squibb
Chronic Hepatitis B
02/05
02/05
NCT00035789: A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen

Completed
3
US
Entecavir
Bristol-Myers Squibb
Chronic Hepatitis B
05/05
05/05
NCT00096785: Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection

Completed
3
69
US, Canada, RoW
entecavir, Baraclude, adefovir
Bristol-Myers Squibb
Hepatitis B, Chronic Disease
01/06
04/08
NCT00975091: Continue Entecavir Rollover From China

Completed
3
600
RoW
Entecavir, Baraclude, BMS-200475
Bristol-Myers Squibb
Chronic Hepatitis B Virus
08/07
08/07
NCT00412529: Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

Completed
3
44
RoW
Entecavir, Telbivudine
Novartis Pharmaceuticals
Hepatitis B, Chronic Hepatitis B
02/08
 
NCT00065507: Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation

Completed
3
195
US, Canada, Europe, RoW
Entecavir (ETV), Baraclude, BMS-200475, Adefovir (ADV)
Bristol-Myers Squibb
Hepatitis B
10/08
05/13
NCT00605384: A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection

Terminated
3
4
US, Europe, RoW
Entecavir + Tenofovir, Baraclude, Adefovir + continuing Lamivudine
Bristol-Myers Squibb
Chronic Hepatitis B
02/09
02/09
NCT00410072 / 2006-000421-62: Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B

Completed
3
669
US, Canada, Europe, RoW
Entecavir, Baraclude, BMS-200475, Entecavir + Tenofovir
Bristol-Myers Squibb
Hepatitis B, Chronic
10/10
10/10
DEFINE, NCT00410202: Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus

Completed
3
629
US, Canada, Europe, RoW
Entecavir, Baraclude, BMS-200475, Tenofovir, Viread, Adefovir, Hepsera, Lamivudine, Epivir
Bristol-Myers Squibb
Hepatitis B, Chronic
01/11
07/12
NCT00395018 / 2006-000453-22: Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection

Completed
3
109
US, Europe, RoW
entecavir, Baraclude, BMS-200475
Bristol-Myers Squibb
Hepatitis B, Chronic
03/11
03/11
NCT01892241: Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNA

Completed
3
74
RoW
Pegasys(Roche), peginterferon alfa-2a, Entecavir
Third Affiliated Hospital, Sun Yat-Sen University
Antiviral Treatment of Chronic Hepatitis B
11/12
02/13
NCT01063036 / 2009-015705-40: Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment

Completed
3
144
Europe
Entecavir, Baraclude®, BMS-200475, Tenofovir, Viread®
Bristol-Myers Squibb
Chronic Hepatitis B
11/12
02/14
NCT01046799 / 2008-005976-28: Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir

Completed
3
20
Europe
Entecavir, Baraclude
HepNet Study House, German Liverfoundation, Hannover Medical School
Liver Transplantation, Hepatitis B, Liver Disease
06/14
10/14
TERESA, NCT01595685: Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B

Completed
3
98
RoW
Telbivudine, Sebivo, Entecavir, Baraclude
Asan Medical Center
Chronic Viral Hepatitis B Without Delta-agent
12/14
12/14
NCT01694264: Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα

Terminated
3
43
RoW
Entecavir, Baraclude (Bristol-Myers Squibb) 0.5mg, Placebo, placebo, prepared by Bristol-Myers Squibb
Seoul National University Hospital, Konkuk University Medical Center, Kyungpook National University Hospital, Kyunghee University Medical Center, Kyung Hee University Hospital at Gangdong, Gachon University Gil Medical Center, Daegu Catholic University Medical Center, Eulji University Hospital, SMG-SNU Boramae Medical Center, The Catholic University of Korea, Severance Hospital, Ajou University School of Medicine, Ewha Womans University Mokdong Hospital, Inha University Hospital, Chonnam National University Hospital, Chonbuk National University Hospital, Chungnam National University Hospital, Hallym University Medical Center, Hanyang University, Dong-A University, Korea University Guro Hospital
Chronic Hepatitis B, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Juvenile Idiopathic Arthritis
08/15
12/15
NCT01580202: Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine

Completed
3
180
RoW
Entecavir, Lamivudine
Seoul National University Hospital
Malignancy, Hepatitis B
06/17
06/17
NCT00051038: Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients

Completed
2/3
US
Entecavir
Bristol-Myers Squibb
Hepatitis B
10/05
10/05

Download Options